Ifrah Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-44,232
| Closed | -$121K | – | 206 |
|
|
2017
Q4 | $121K | Buy |
44,232
+647
| +1% | +$1.77K | 0.04% | 193 |
|
|
2017
Q3 | $148K | Buy |
43,585
+313
| +0.7% | +$1.06K | 0.06% | 188 |
|
|
2017
Q2 | $107K | Sell |
43,272
-692
| -2% | -$1.71K | 0.04% | 181 |
|
|
2017
Q1 | $100K | Sell |
43,964
-1,347
| -3% | -$3.06K | 0.04% | 183 |
|
|
2016
Q4 | $96K | Sell |
45,311
-2,287
| -5% | -$4.85K | 0.04% | 186 |
|
|
2016
Q3 | $159K | Buy |
47,598
+13,955
| +41% | +$46.6K | 0.06% | 185 |
|
|
2016
Q2 | $106K | Buy |
33,643
+1,107
| +3% | +$3.49K | 0.04% | 192 |
|
|
2016
Q1 | $108K | Buy |
32,536
+2,106
| +7% | +$6.99K | 0.04% | 189 |
|
|
2015
Q4 | $108K | Sell |
30,430
-3,794
| -11% | -$13.5K | 0.04% | 185 |
|
|
2015
Q3 | $172K | Buy |
34,224
+339
| +1% | +$1.7K | 0.07% | 184 |
|
|
2015
Q2 | $218K | Buy |
33,885
+62
| +0.2% | +$399 | 0.08% | 182 |
|
|
2015
Q1 | $238K | Buy |
33,823
+479
| +1% | +$3.37K | 0.09% | 178 |
|
|
2014
Q4 | $257K | Sell |
33,344
-912
| -3% | -$7.03K | 0.1% | 162 |
|
|
2014
Q3 | $256K | Buy |
34,256
+2,954
| +9% | +$22.1K | 0.1% | 159 |
|
|
2014
Q2 | $303K | Buy |
31,302
+458
| +1% | +$4.43K | 0.11% | 139 |
|
|
2014
Q1 | $256K | Buy |
+30,844
| New | +$256K | 0.1% | 162 |
|